Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy without macular edema (bilateral)
ICD-10 E09.3593 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy without macular edema (bilateral).
E09.3593 refers to diabetes mellitus that is induced by drugs or chemicals, specifically characterized by the presence of proliferative diabetic retinopathy without macular edema in both eyes. This condition arises when certain medications or toxic substances lead to insulin resistance or impaired insulin secretion, resulting in hyperglycemia. Proliferative diabetic retinopathy is a severe complication of diabetes, marked by the growth of new blood vessels in the retina, which can lead to vision loss. The absence of macular edema indicates that there is no swelling in the macula, the central part of the retina responsible for sharp vision. Management of this condition often involves controlling blood glucose levels through insulin therapy or other medications, regular monitoring of HbA1c levels, and addressing the retinopathy through ophthalmologic interventions. Understanding the underlying cause of the diabetes, whether it be medication-induced or due to other factors, is crucial for effective treatment and prevention of further complications.
Detailed medication history, HbA1c levels, and management plans.
Patients presenting with new-onset diabetes due to medication, monitoring of diabetes management.
Ensure clarity on the drug-induced nature of diabetes and its management.
Detailed retinal examination findings, staging of retinopathy, and treatment plans.
Patients with diabetic retinopathy requiring laser treatment or injections.
Document the absence of macular edema and the specific type of retinopathy.
Used for follow-up visits for diabetic retinopathy management.
Document visual acuity, fundoscopic findings, and treatment plan.
Ophthalmologists should ensure detailed documentation of retinopathy stages.
Common medications include glucocorticoids, certain antipsychotics, and some chemotherapy agents. It's essential to document the specific medication responsible for the diabetes.
